| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Net loss | ||||||||
-422,954 | -304,706 | -227,948 | -194,096 | -156,339 | -127,502 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Share-based compensation expense | ||||||||
25,879 | 21,144 | 15,865 | 12,621 | 10,682 | 7,733 | 0 | 0 | 0 |
Loss on early extinguishment of debt | ||||||||
- | -1,501 | 0 | 0 | 0 | - | - | - | - |
Loss from remeasurement of development derivative liability | ||||||||
-82,509 | -14,839 | 0 | 0 | 0 | - | - | - | - |
Amortization of right-of-use assets | ||||||||
0 | - | 0 | 0 | 0 | - | - | - | - |
Depreciation expense | ||||||||
283 | 239 | 0 | 0 | 0 | - | - | - | - |
Amortization of debt discounts | ||||||||
- | - | - | - | 0 | - | - | - | - |
Amortization of term loan facility discounts | ||||||||
- | - | - | - | 0 | - | - | - | - |
Amortization of discounts for convertible notes, net of financing costs | ||||||||
0 | - | - | - | - | - | - | - | - |
Accretion of discounts for promissory note | ||||||||
- | - | - | - | - | 71 | 0 | 0 | 0 |
Accretion of discounts for term loan facility | ||||||||
- | - | - | - | - | 582 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | ||||||||
Refundable research and development credit | ||||||||
- | - | - | - | - | -299 | 0 | 0 | 0 |
Prepaid assets | ||||||||
2,296 | -4,531 | -2,112 | 3,120 | 12,389 | 19,275 | 0 | 0 | 0 |
Other current assets | ||||||||
133 | -287 | 1,180 | 3,356 | 371 | 309 | 0 | 0 | 0 |
Other assets | ||||||||
736 | 322 | 0 | 0 | 0 | - | - | - | - |
Accounts payable | ||||||||
-8,783 | -1,640 | 6,585 | 8,918 | 7,571 | 6,587 | 0 | 0 | 0 |
Accrued expenses | ||||||||
37,698 | 50,453 | 20,083 | 15,403 | 5,178 | 2,234 | 0 | 0 | 0 |
Other liabilities | ||||||||
- | -158 | 0 | 0 | 0 | - | - | 0 | 0 |
Net cash used in operating activities | ||||||||
-283,924 | -211,135 | -173,541 | -153,076 | -143,865 | -131,240 | 0 | 0 | 0 |
Investing Activities | ||||||||
Purchase of property and equipment | ||||||||
1,253 | 1,693 | 0 | 0 | 0 | - | - | - | - |
Purchase of available-for-sale securities | ||||||||
0 | - | - | - | - | - | - | - | - |
Net cash used in investing activities | ||||||||
-228,672 | -1,693 | 0 | 0 | 0 | - | - | - | - |
Deferred issuance costs | ||||||||
- | - | - | - | - | - | - | - | 0 |
Proceeds from issuance of common stock, net of issuance costs | ||||||||
381,247 | 109,581 | 0 | 0 | 0 | - | - | - | - |
Proceeds from development derivative liability | ||||||||
80,000 | 120,000 | 0 | 0 | 0 | - | - | - | - |
Proceeds from exercise of stock options | ||||||||
0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
Repayment of term loan facility | ||||||||
- | 21,701 | 0 | 0 | 0 | - | - | - | - |
Net cash provided by financing activities | ||||||||
643,390 | 388,541 | 388,447 | 189,459 | 280,098 | 131,903 | 0 | 0 | 0 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||||
-143 | 4 | 0 | 0 | 0 | - | - | - | - |
Net increase in cash, cash equivalents and restricted cash | ||||||||
130,650 | 175,717 | 213,353 | 35,289 | 135,315 | 624 | 0 | 0 | 0 |
Cash paid for Interest | ||||||||
4,228 | 987 | 1,436 | 1,536 | 1,852 | 1,816 | 0 | 0 | 0 |